Result of Voting for Directors at Annual and Special Meeting
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
TORONTO, April 17, 2020 (GLOBE NEWSWIRE) -- Fairfax Africa Holdings Corporation (TSX: FAH.U) announces the results of the vote on Directors at its April 15, 2020 annual and special meeting.
Each of the nominee directors listed in the Corporation’s management proxy circular dated March 6, 2020 was elected as a director, without a vote by ballot being conducted. The Corporation received proxies with regard to voting on the nine directors nominated for election, directing as set forth in the table below:
| Name of Nominee | Vote For (Aggregate) | % |
Withhold Vote (Aggregate) |
% |
| Hisham Ezz Al-Arab | 1,505,429,786 | 99.2 | 11,850,100 | 0.8 |
| Lt. Gen. (ret.) Roméo Dallaire | 1,505,661,038 | 100.0 | 287,500 | 0.0 |
| Christopher D. Hodgson | 1,505,660,313 | 100.0 | 323,750 | 0.0 |
| Quinn McLean | 1,505,660,313 | 100.0 | 323,750 | 0.0 |
| Ndidi Okonkwo Nwuneli | 1,505,660,688 | 100.0 | 305,000 | 0.0 |
| Richard Okello | 1,505,660,188 | 100.0 | 330,000 | 0.0 |
| Paul C. Rivett | 1,505,661,063 | 100.0 | 286,250 | 0.0 |
| V. Prem Watsa | 1,505,661,313 | 100.0 | 273,750 | 0.0 |
| Michael Wilkerson | 1,505,660,813 | 100.0 | 298,750 | 0.0 |
A replay of Fairfax Africa’s annual and special meeting will be available until 5:00 p.m. (Eastern time) on Wednesday, April 29, 2020. The replay may be accessed at (866) 402-3743 (Canada and the U.S.) or 1 (203) 369-0551 (International).
Fairfax Africa is an investment holding company. Its investment objective is to achieve long-term capital appreciation, while preserving capital, by investing in public and private equity securities and debt instruments in Africa and African businesses or other businesses with customers, suppliers or business primarily conducted in, or dependent on, Africa.
| For further information, contact: | Keir Hunt, Corporate Secretary |
| (416) 646-4180 |
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
